Modification of the biological activity of chemokines by dipeptidyl peptidase IV - A side effect in the use of inhibitors?

Advances in Experimental Medicine and Biology

Volumn 524, Issue , 2003, Pages 37-47

  Mentlein, Rolf ^a   Schiemann, Florian ^b   Ludwig, Andreas ^b   Brandt, Ernst ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b RESEARCH CENTER BORSTEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CHEMOKINE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; ENZYME INHIBITOR; GAMMA INTERFERON INDUCIBLE T CELL ALPHA; NEUROPEPTIDE; PEPTIDE HORMONE; UNCLASSIFIED DRUG;

CHEMOTAXIS; CONFERENCE PAPER; DRUG ACTIVITY; DRUG SCREENING; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; PRIORITY JOURNAL; PROTEIN DEGRADATION;

AMINO ACID SEQUENCE; ANTIGENS, CD26; CHEMOKINES; CHEMOKINES, CXC; HUMANS; MOLECULAR SEQUENCE DATA; NEUROPEPTIDES;

EID: 0038363937     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (22)

1. Gorrell, M. D., Gysbers, G., and McCaughan, G. W., 2001, CD26: A multifunctional integral membrane and secreted protein of activated lymphocytes. Scand. J. Immunol. 54: 249-264.
2. Audustyns, K., Bal, G., Thonus, G., Belyaev, A., Zhang, X. M., Bollaert, W., Lambeir, A. M., Durinx, C., Goossens, F., and Haemers, A., 1999, The unique properties of dipeptidyl peptidase IV (DPP IV / CD26) and the therapeutic potential of DPP IV inhibitors. Current Med. Chem. 6: 311-327.
3. Kähne, T., Lendeckel, U., Wrenger, S., Neubert, K., Ansorge, S., and Reinhold, D., 1999, Dipeptidyl peptidase IV: A cell surface peptidase involved in regulating T cell growth. Int. J. Mol. Med. 4: 3-15.
4. Mentlein, R., 1999, Dipeptidyl-peptidase IV (CD26) - role in the inactivation of regulatory peptides. Regul. Peptides 85: 9-24.
5. De Meester, I., Korom, S., Van Damme, J., and Scharpé, S., 1999, CD26, let it cut or cut it down. Immunoloy Today 20: 367-375.
6. Scharpé, S., and De Meester, I., 2001, Peptide truncation by dipeptidyl peptidase IV: A new pathway for drug discovery? Verhandelingen van de Koninklijke Academie voor Geneeskunde van Belgie LXIII: 5-33.
7. Mentlein, R., Dahms, P., Grandt, D., and Krüger, R., 1993, Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV. Regul. Peptides 49: 133-144.
8. Mentlein, R., Gallwitz, B., and Schmidt, W. E., 1993, Dipeptidyl peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36) amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur. J. Biochem. 214: 829-835.
9. Deacon, C. F., Hughes, T. E., and Holst, J. J., 1998, Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig. Diabetes 47: 764-769.
10. Pederson, R. A., White, H. A., Schlenzig, D., Pauly, R. P., McIntosh, C. H. S., and Demuth, H.-U., 1998, Improved tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide. Diabetes 47: 1253-1258.
11. Oravecz, T., Pall, M., Rodriquez, G., Gorrell, M. D., Ditto, M., Nguyen, N. Y., Boykins, R., Unsworth, E., and Norcross, M. A. 1997, Regulation of the receptor specificty and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J. Exp. Med. 186: 1865-1872.
12. Proost, P., De Meester, I., Scholz, D., Struyf, S., Lambeir, A.M., Wuyts, A., Opdenakker, G., De Clerq, E., Scharpe, S., Van Damme, J., 1998, Aminoterminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV infection. J. Biol. Chem. 273: 7222-7227.
13. Proost, P., Struyf, S., Schols, D., Durinx, C., Wuyts, A., Lenaerts, J. P., De Clerq, E., De Meester, I., and Van Damme, J., 1998, Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha. FEBS Lett. 432: 73-76.
14. Shioda, T., Kato, H., Ohnishi, Y., Tashiro, K., Ikegawa, M., Nakayama, E.E., Hu, H., Kato, A., Sakai, Y., Liu, H., Honjo, T., Nomot, A., Iwamoto,A., Morimoto, C., Nagai, Y., 1998, Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage. Proc. Natl. Acad. Sci. USA 95: 6331-6336.
15. Struyf, S., Proost, P., Schols, D., De Clerq, E., Opdenakker, G.,. Lenaerts, J.-P., Detheux, M., Parmentier, M., De Meester, I., Scharpé, S., Van Damme, J., 1999, CD26/Dipeptidyl-peptidase IV down regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3. J. Immunol. 162: 4903-4909.
16. Ludwig, A., Schiemann, F., Mentlein, R., Lindner, B., Brandt, E., 2002, Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine. J. Leukoc. Biol. 72: 183-191
17. Proost, P., Struyf, S., Schols, D., Opdenakker, G., Sozzani, S., Allavena, P., Mantovani, A., Augustyns, K., Bal, G., Haemers, A., Lambeir, A.M., Scharpe, S., Van Damme, J. De Meester, I., 1999, Truncation of macrophage-derived chemokine by CD26/dipeptidyl peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction. J. Biol. Chem. 274: 3988-3993.
18. Proost, P., Menten, P., Struyf, S., Schutyser, E., De Meester, I., and Van Damme, J., 2000, Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist. Blood 96: 1674-1680.
19. Brandt, E., Van Damme, J., Flad, H.D., 1991, Neutrophils can generate their activator neutrophil-activating peptide 2 by proteolytic cleavage of platelet-derived connective tissue-activating peptide III. Cytokine 3: 311-321.
20. Hebert, C. A., Luscinskas, F. W., Kiely, J. M., Luis, E. A., Darbonne, W. C., Bennett, G. L., Liu, C. C., Obin, M. S., Gimbrone, M. A. Jr., Baker, J. B., 1990, Endothelial and leukocyte forms of IL-8. Conversion by thrombin and interactions with neutrophils. J. Immunol. 145: 3033-3040.
21. Padrines, M.., Wolf, M.., Walz, A.., Baggiolini, M., 1994, Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3. FEBS Lett. 352: 231-235.
22. Lambeir, A. M., Proost, P., Durinx, C., Bal, G., Senten, K., Augustyns, K., Scharpé, S., Van Damme, J., De Meester, I., 2001, Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family. J. Biol. Chem. 10: 29839-29845.